MDT financials
Medtronic Plc · end-of-day data as of Oct 16, 2026
Medtronic Plc
$94.75+14.8%
Buy · 29 analystsPT $98.54 +4.0%
MDT reported revenue of $9.76B for the quarter ended Jul 31, 2026 (Q1 FY2027), up 13.7% from a year earlier. It posted diluted EPS of $1.14, free cash flow of $1.29B and a net margin of 15.1%.
Valuation
- P/E23.3x
- P/E vs own-3.5%
- P/E vs sector-17.1%
- FCF yield+5.1%
- Market cap$121B
Quarterly results
Q1 FY2027: Revenue +13.7% year over year, free cash flow 13.2% of revenue, operating margin 18.1%.
RevenueFree cash flow
| Q1 FY2027 | Jul 31, 2026 | $9.76B | 1.14 | $1.29B | 65.0% | 18.1% | 15.1% |
| Q4 FY2026 | Apr 24, 2026 | $9.81B | 0.96 | $2.08B | 75.9% | 15.9% | 12.7% |
| Q3 FY2026 | Jan 23, 2026 | $9.02B | 0.89 | $2.3B | 64.9% | 19.7% | 12.7% |
| Q2 FY2026 | Oct 24, 2025 | $8.96B | 1.07 | $457M | 60.3% | 18.8% | 15.3% |
| Q1 FY2026 | Jul 25, 2025 | $8.58B | 0.81 | $584M | 57.7% | 16.8% | 12.1% |
| Q4 FY2025 | Apr 25, 2025 | $8.93B | 0.82 | $2.07B | 64.7% | 16.1% | 11.8% |
| Q3 FY2025 | Jan 24, 2025 | $8.29B | 1.01 | $2.1B | 66.5% | 19.9% | 15.6% |
| Q2 FY2025 | Oct 25, 2024 | $8.4B | 0.99 | $554M | 64.9% | 19.0% | 15.1% |
| Q1 FY2025 | Jul 26, 2024 | $7.92B | 0.80 | $466M | 65.1% | 16.1% | 13.2% |
| Q4 FY2024 | Apr 26, 2024 | $8.59B | 0.49 | $2.35B | 64.6% | 12.3% | 7.6% |
| Q3 FY2024 | Jan 26, 2024 | $8.09B | 0.99 | $2.13B | 65.6% | 18.3% | 16.3% |
| Q2 FY2024 | Oct 27, 2023 | $7.98B | 0.68 | $200M | 65.4% | 16.8% | 11.4% |